u/Asleep-Procedure-131 · 151d agono track record yet
Long 36,300 shares of CGTX
How come no one is talking about CGTX?
CGTX announced phase 3 trial data with multiple near-term catalysts lined up in June, including the H.C. Wainwright Summit, Annual Shareholder Meeting, and FDA Written Minutes on June 19-20, which the author identifies as the primary catalyst. The phase 3 design is public and 3,000 institutional investors have been briefed, positioning the stock for potential upside as these catalysts approach.
At post $1.36Now $0.71-47.8% since postedas of Nov 2, 4:15 PM ET
1d-5.1%
3d-5.1%
1w-11.8%
1m-14.0%
3m-22.8%
6m—
1y—